Study Of Palbociclib In Combination With Letrozole As Treatment Of Postmenopausal Women With Hormone Receptor Positive, HER2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate
Phase of Trial: Phase III
Latest Information Update: 02 Apr 2018
At a glance
- Drugs Letrozole (Primary) ; Palbociclib (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Registrational
- Sponsors Pfizer
- 29 Jan 2018 Planned End Date changed from 1 Dec 2018 to 14 Dec 2018.
- 29 Jan 2018 Planned primary completion date changed from 1 Dec 2018 to 14 Dec 2018.
- 12 Jan 2018 Planned End Date changed from 31 Oct 2018 to 1 Dec 2018.